In addition, mutually exclusive KRAS and MAP2K1 mutations were described in one-third of the cases of RDD, suggesting that this subgroup is clonal and involves activation of the MAPK/ERK pathway (46). This evidence concerns the gene MAP2K1 and sinus histiocytosis with massive lymphadenopathy.